Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Rep. Marjorie Taylor Greene (R-Ga.) has been actively buying stocks in 2025 and is back with more than a dozen more trades less than two weeks after her last disclosure. Here's the latest transactions made by the congresswoman in May. What Happened: Greene ranks 24th among the best-performing members of Congress based on their trades in 2024. The Congresswoman gained 30.2% for the year, outperforming the S&P 500 gain of 24.9%. Greene recently disclosed over 50 new stock trades in early May, which came on top of some potentially perfectly timed trades that happened before President Donald Trump’s pause of tariffs, which sent the market soaring. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today. Here are Greene’s most recent trades made on May 14, per the Benzinga Government Trades page. All purchases made were listed as between $1,001 to $15,000 unless otherwise indicated. UnitedHealth Group (NYSE:UNH): $15,000 to $50,000 Alphabet (NASDAQ:GOOG) Amgen Inc (NASDAQ:AMGN) Advanced Micro Devices (NASDAQ:AMD) Blackstone (NYSE:BX) Cardinal Health (NYSE:CAH) Chevron Corporation (NYSE:CVX) Corning Inc (NYSE:GLW) Dollar General Corporation (NYSE:DG) Eli Lilly (NYSE:LLY) Impinj Inc (NASDAQ:PI) MercadoLibre Inc (NASDAQ:MELI): $15,000 to $50,000 Meta Platforms (NASDAQ:META) Morgan Stanley (NYSE:MS) Netflix Inc (NASDAQ:NFLX) NVIDIA Corporation (NASDAQ:NVDA) ServiceNow (NYSE:NOW) Tesla Inc (NASDAQ:TSLA) The Hershey Company (NYSE:HSY) Greene also disclosed buying an additional $1,000 to $15,000 in UnitedHealth stock on May 16. The Congresswoman also disclosed buying $100,000 to $250,000 in US Treasury Bills on May 16. Greene has bought $2.82 million in stocks in 2025 according to data from Quiver Quantitative with only $75,000 in stock sales. The Congresswoman bought $3.89 million in stocks in 2024 with $65,000 in sales. Why It’s Important: Members of Congress are allowed to buy and sell stocks as long as they properly disclose the transaction. The process has drawn scrutiny from the public and retail investors as members of Congress could have inside information and time their trades accordingly. Committee assignments in particular, often draw red flags from investors. Greene serves on the House Committee on Oversight and Accountability and the House Committee on Homeland Security with several subcommittee appointments. The congresswoman’s past trade in technology and cybersecurity stocks has drawn attention with her role within Homeland Security. Story Continues Greene's past trades of Palantir Technologies and a Bitcoin ETF have drawn criticism along with the timing of her trades, as she is a close ally to President Donald Trump. See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000. When asked previously about buying stocks earlier this year that soared days later after Trump announced a pause to tariffs, Greene brushed aside the criticism. "I think that criticism is laughable. President Trump has been talking about tariffs for decades," Greene told reporters when asked about the trades at a recent town hall event in Georgia in a clip shared by Unusual Whales. The congresswoman used the opportunity to boast about her stock performance, which ranked her as one of the top trading members of Congress in 2024. "I don't place my buys and sells,” Greene said, citing an agreement she has with her portfolio manager, who handles all the buying and selling of stocks. "He did a great job. Guess what he did. He bought the dip. And that's what anybody that has financial sense does.” Greene also said her portfolio manager did not have inside information, everything was public and a potential tariff pause wasn't a secret. Sen. Josh Hawley (R-Mo.) has reintroduced legislation that would ban members of Congress from trading or holding individual stocks. The bill is known as the Preventing Elected Leaders from Owning Securities and Investments Act, or PELOSI Act based on the first letter of each of the main words. The name takes aim at the congresswoman and former Speaker of the House Nancy Pelosi (D-Calif.). "Members of Congress should be fighting for the people they were elected to serve — not day trading at the expense of their constituents," Hawley said. "Americans have seen politician after politician turn a profit using information not available to the general public." Hawley said the bill will help "restore Americans' trust in our nation's legislative body." Hawley's bill is being reintroduced as President Donald Trump said he would support such a ban. "Well, I watched Nancy Pelosi get rich through insider information, and I would be okay with it. If they send it to me, I would do it," Trump told TIME. Trump said he would sign the ban if the bill passes Congress. While Pelosi makes headlines for her trades, it's important to remember that it is both Republican and Democratic members of Congress who are profiting from buying and selling stocks and options while in office, with some trades coming with questionable timing or having a connection to committees they serve on. In 2024, a list of the top-performing traders in Congress included six Republicans and four Democrats. Read Next: Hasbro, MGM, and Skechers trust this AI marketing firm — Invest at $0.60/share before it's too late. Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold. Image: Shutterstock Send To MSN: Send to MSN This article Marjorie Taylor Greene Goes Shopping For Tesla, Netflix, UnitedHealth And More: 19 Stocks The Congresswoman Bought originally appeared on Benzinga.com View Comments
Marjorie Taylor Greene Goes Shopping For Tesla, Netflix, UnitedHealth And More: 19 Stocks The Congresswoman Bought
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...